Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.22 USD | -0.87% | +5.93% | -5.24% |
Evolution of the average Target Price on Entrada Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Entrada Therapeutics, Inc.
Oppenheimer | |
HC Wainwright | |
Goldman Sachs | |
Evercore ISI | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- TRDA Stock
- Consensus Entrada Therapeutics, Inc.